In superficial and deep melanomas, the proportion of HAS2 positive melanocytic cells was significantly lower (mean 51-75% and 26-50%, respectively) than in in situ melanomas (p=0.043 and p=0.007, respectively). This evidence concerns the gene HAS2 and melanoma.